Physician profile
Steven A Acker
NPI 1003889205
$500.40
in general payments reported to CMS, 2019-2025
17 companies · $51.81 in 2025
The $51.81 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.00 · 2020: $11.22 · 2021: $98.40 · 2022: $170 · 2023: $14.24 · 2024: $63.58 · 2025: $51.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $129.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $70.89 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $66.10 | 2022 | |
| Medtronic, INC. | $51.81 | 2025 | Synchromedii |
| Boston Scientific Corporation | $39.97 | 2021-2024 | Varithena Administration Pack |
| Amgen INC. | $33.83 | 2021-2022 | |
| Smith+Nephew, INC. | $27.70 | 2019 | |
| Sanofi-Aventis U.S. LLC | $26.06 | 2022-2023 | |
| Endo Pharmaceuticals INC. | $22.85 | 2020-2021 | |
| Stryker Corporation | $22.64 | 2024 | Gamma, T2 Alpha |
| Janssen Biotech, INC. | $22.16 | 2022 | |
| Avanir Pharmaceuticals, INC. | $20.92 | 2022 | |
| Pinnacle, INC | $19.55 | 2024 | |
| Spr Therapeutics, INC | $17.49 | 2021 | |
| Ethicon US, LLC | $16.74 | 2019 | |
| Linvatec Corporation | $14.09 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $13.95 | 2021 | |
| Ferring Pharmaceuticals INC. | $13.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Acker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.